Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX – Get Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 14,800 shares, a decline of 50.3% from the March 31st total of 29,800 shares. Based on an average daily volume of 23,800 shares, the days-to-cover ratio is currently 0.6 days. Approximately 1.7% of the shares of the company are sold short.
Virpax Pharmaceuticals Stock Performance
VRPX opened at $2.87 on Friday. The business has a fifty day simple moving average of $3.70 and a 200 day simple moving average of $4.47. Virpax Pharmaceuticals has a 1 year low of $2.40 and a 1 year high of $11.77.
Virpax Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Virpax Pharmaceuticals
- The “How” and “Why” of Investing in 5G Stocks
- Hasbro’s Management Made All the Right Calls This Quarter
- Where to Find Earnings Call Transcripts
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What is the S&P 500 and How It is Distinct from Other Indexes
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Virpax Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virpax Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.